CureMatch Partnering With Patient Power To Educate And Empower Patients And Oncologists Regarding Personalized Cancer Treatments
Life Sciences Jobs ... Source: BioSpace
Tango Therapeutics Officially Debuts With $55 Million and a Crew of Superstar Scientific Advisers
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-investor.jpg" NAME"Tango Therapeutics Officially Debuts With $55 Million and a Crew of Superstar Scientific Advisers" ALT"Tango Therapeutics Officially Debuts With $55 Million and a Crew of Superstar Scientific Advisers"March…
Integer CEO Steps Down
Life Sciences Jobs ... Source: BioSpace
Massachusetts' Agenus to Phase Out 20% of Jobs, Shutter Switzerland Facility in Restructuring
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-job-cuts.jpg" NAME"Massachusetts' Agenus to Phase Out 50 Jobs, Shutter Switzerland Facility in Restructuring" ALT"Massachusetts' Agenus to Phase Out 50 Jobs, Shutter Switzerland Facility in Restructuring"March 30, 2017By Mark... Source:…
Tonix Pharma Prices Public Offering Of 1,800,000 Shares Of Common Stock
Life Sciences Jobs ... Source: BioSpace
LAM Therapeutics Scores $58 Million and a New Clinical Program in Cancer
Life Sciences Jobs ... Source: BioSpace
FDA Rejects Mylan’s Generic Advair ANDA after Denying Sandoz’s Petition
The FDA issued a complete response letter Wednesday to Mylan for its generic version of the Advair Diskus asthma inhaler developed by GlaxoSmithKline. Source: Drug Industry Daily
FDA Committee Unanimously Recommends New Subcutaneous Dose of Rituxan
An FDA advisory committee unanimously voted to recommend approval of Genentech’s new subcutaneous formulation of Rituxan for several blood cancer indications. Source: Drug Industry Daily
Price Says HHS, Trump Developing Plan to Lower Drug Prices
HHS Secretary Tom Price told a congressional subcommittee that he and President Trump are developing a plan to reduce drug prices. Source: Drug Industry Daily
Gottlieb to Recuse Himself from Agency Decisions on More than 20 Companies
FDA Commissioner nominee Scott Gottlieb will recuse himself for one year from decisions relating to more than 20 companies, including large drugmakers, according to his ethics disclosure form. Source: Drug…
- Go to the previous page
- 1
- …
- 498
- 499
- 500
- 501
- 502
- 503
- 504
- …
- 610
- Go to the next page